Liver cancer ablation with extracorporeal high-intensity focused ultrasound

R. Yang, N. T. Sanghvi, F. J. Rescorla, K. K. Kopecky, J. L. Grosfeld

Research output: Contribution to journalReview article

63 Scopus citations

Abstract

Recent animal studies have demonstrated the capacity of high-intensity focused ultrasound (HIFU) to extracorporeally ablate selective tissue targets in the liver without requiring surgical exposure of the liver or insertion of instruments into the liver. The potential value of HIFU as a noninvasive local treatment for human hepatic cancers has attracted considerable interest. This report reviews the current status of HIFU research and sets forth questions for future study.

Original languageEnglish (US)
Pages (from-to)17-22
Number of pages6
JournalEuropean urology
Volume23
Issue numberSUPPL. 1
DOIs
StatePublished - Jan 1 1993

    Fingerprint

Keywords

  • Intense focused ultrasound
  • Liver cancer
  • Noninvasive therapy

ASJC Scopus subject areas

  • Urology

Cite this